Dr. Martin Majer, MD

Dr. Majer practices at Interventional Radiation Oncology of California Inc in Apple Valley, California.

Dr. Majer's NPI, 1376749234, was assigned on June 26, 2007. Dr. Majer graduated from Charles University - Karlova and Hradci Faculty of Medicine in 1987. Dr. Majer holds Montana license MED-PHYS-LIC-112718.

Dr. Majer's primary practice is Interventional Radiation Oncology of California Inc, at 18564 Us-18, Apple Valley, CA 92307 in San Bernardino County. The practice phone is (760) 503-5910.

Dr. Majer's primary practice is Interventional Radiation Oncology of California Inc in Apple Valley, California. Dr. Majer is also affiliated with Riverside Community Hospital. The medical group on file is Western Radiation Oncology. Dmand AI also links Dr. Majer to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Majer practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Majer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Majer is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Majer's licenses on file in 4 states: Montana, Oregon, California and Utah.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT) and lung cancer among the conditions Dr. Majer treats.

CMS data shows 265 Medicare services from Dr. Majer across 5 procedure codes in 2024, for 121 Medicare patients. Medicare paid $21,601 for them.

CMS counts 121 Medicare patients who saw Dr. Majer in 2024. The largest group is 65 to 74, with 68 patients. 69% of them have high blood pressure, and 61% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Majer's median patient age at 69, with 62% women.

In 2024, Dr. Majer wrote 285 Medicare Part D claims for 79 patients. 74% of them were for generic drugs. CMS names the drug for 139 of them, across 8 drugs with 11 or more claims each, at $412,385 in total drug cost. In 2023, CMS named 385 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Majer for performance year 2024, reported as part of a group. Dr. Majer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Majer as offering telehealth.

Dmand AI links 9 papers to Dr. Majer in 2012. The most frequent topics are Base Sequence, Diabetes Mellitus, Type 2 and RNA, Messenger. Dr. Majer has published most often in Cancer. Dr. Majer's most frequent co-author is Scott K. Kuwada, MD.

CMS Open Payments shows 249 general payments to Dr. Majer from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,772.

Dr. Majer graduated from Charles University - Karlova and Hradci Faculty of Medicine in 1987.

Dr. Majer is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.